Naturlose (D-Tagatose) Efficacy Evaluation Trial

NCT00955747 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

494

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: Tagatose
DRUG: Sugar Substitute Splenda

Sponsor

Robert Lodder

Collaborators

[object Object]